Related references
Note: Only part of the references are listed.mTOR and cancer: many loops in one pathway
Alejo Efeyan et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Targeting metabolic transformation for cancer therapy
Daniel A. Tennant et al.
NATURE REVIEWS CANCER (2010)
PIK3CA mutations in human solid tumors Role in sensitivity to various therapeutic approaches
Giovanni Ligresti et al.
CELL CYCLE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Tenets of PTEN tumor suppression
Leonardo Salmena et al.
CELL (2008)
Brick by brick: metabolism and tumor cell growth
Ralph J. DeBerardinis et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy
Philip D. Hardt et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
C. B. Knobbe et al.
ONCOGENE (2008)
Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses
Lorna Whyte et al.
CANCER RESEARCH (2007)
Resveratrol inhibits glucose metabolism in human ovarian cancer cells
Angela Kueck et al.
GYNECOLOGIC ONCOLOGY (2007)
Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9
Yan Li et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2006)
Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas
Anthony C. Faber et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Metabolomic identification of novel biomarkers of myocardial ischemia
MS Sabatine et al.
CIRCULATION (2005)
Pyruvate kinase type M2 and its role in tumor growth and spreading
S Mazurek et al.
SEMINARS IN CANCER BIOLOGY (2005)
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
PK Majumder et al.
NATURE MEDICINE (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines
P Fustier et al.
BRITISH JOURNAL OF CANCER (2003)
Pyruvate kinase type M2: a crossroad in the tumor metabolome
S Mazurek et al.
BRITISH JOURNAL OF NUTRITION (2002)
Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage
A Sgambato et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2001)
The allosteric regulation of pyruvate kinase - A site-directed mutagenesis study
G Valentin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
